Tramadol induces changes in Δ-FosB, µ-opioid receptor, and p-CREB level in the nucleus accumbens and prefrontal cortex of male Wistar rat

References

• Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83(1):85–90.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Senay EC, Woody GE. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 1999;57(1):7–22.
   PubMed Web of Science ®Google Scholar
• Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn-Schmiedeberg’s archiv pharmacol 2000;362(2):116–21.
   PubMed Web of Science ®Google Scholar
• Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am J Med 1996;101(1A):47S–53S.
   PubMedGoogle Scholar
• Minami K, Sudo Y, Miyano K, Murphy RS, Uezono Y. micro-Opioid receptor activation by tramadol and O-desmethyltramadol (M1). J Anesth 2015;29(3):475–79. doi:10.1007/s00540-014-1946-z.
   PubMed Web of Science ®Google Scholar
• Sagata K, Minami K, Yanagihara N, Shiraishi M, Toyohira Y, Ueno S, Shigematsu A. Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells. Anesth Analg 2002;94(4):901–06. table of contents.
   PubMed Web of Science ®Google Scholar
• O’Connor EC, Mead AN. Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacol Biochem Behav 2010;96(3):279–86. doi:10.1016/j.pbb.2010.05.018.
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, Bruckmann W, Friderichs E. Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol. Neurosci Lett 2002;329(1):25–28.
   PubMed Web of Science ®Google Scholar
• Sprague JE, Leifheit M, Selken J, Milks MM, Kinder DH, Nichols DE. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse 2002;43(2):118–21. doi:10.1002/syn.10025.
   PubMed Web of Science ®Google Scholar
• Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G, Goodman RH. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004;119(7):1041–54. doi:10.1016/j.cell.2004.10.032.
   PubMed Web of Science ®Google Scholar
• Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 2001;14(7):1091–104.
   PubMed Web of Science ®Google Scholar
• Alberini CM. Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 2009;89(1):121–45. doi:10.1152/physrev.00017.2008.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 1997;7(5):713–19.
   PubMed Web of Science ®Google Scholar
• Morgan JI, Curran T. Immediate-early genes: ten years on. Trends Neurosci 1995;18(2):66–67.
   PubMed Web of Science ®Google Scholar
• Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998;21(3):467–76.
   PubMed Web of Science ®Google Scholar
• Kelz MB, Nestler EJ. deltaFosB: a molecular switch underlying long-term neural plasticity. Curr Opin Neurol 2000;13(6):715–20.
   PubMed Web of Science ®Google Scholar
• Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine’s psychomotor and rewarding effects. Proc Natl Acad Sci USA 1997;94(19):10397–402.
   PubMed Web of Science ®Google Scholar
• Radbruch L, Glaeske G, Grond S, Munchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglgansberger W, Hoffmann-Menzel H, et al. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Substance Abuse 2013;34(3):313–20. doi:10.1080/08897077.2012.735216.
   PubMed Web of Science ®Google Scholar
• Nazarzadeh M, Bidel Z, Carson KV. The association between tramadol hydrochloride misuse and other substances use in an adolescent population: phase I of a prospective survey. Addict Behav 2014;39(1):333–37. doi:10.1016/j.addbeh.2013.09.013.
   PubMed Web of Science ®Google Scholar
• Abdel-Zaher AO, Abdel-Rahman MS, Elwasei FM. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress. Neurotoxicology 2011;32(6):725–33. doi:10.1016/j.neuro.2011.08.001.
   PubMed Web of Science ®Google Scholar
• Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology 2010;211(4):457–66. doi:10.1007/s00213-010-1919-3.
   PubMed Web of Science ®Google Scholar
• Tjaderborn M, Jonsson AK, Ahlner J, Hagg S. Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf 2009;18(12):1192–98. doi:10.1002/pds.1838.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Narita M, Miyoshi K, Shindo K, Okutsu D, Suzuki M, Higashiyama K, Suzuki T. Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice. Psychopharmacology 2008;200(3):307–16. doi:10.1007/s00213-008-1180-1.
   PubMed Web of Science ®Google Scholar
• Narita M, Funada M, Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001;89(1):1–15. doi:10.1016/S0163-7258(00)00099-1.
   PubMed Web of Science ®Google Scholar
• Zastawny RL, George SR, Nguyen T, Cheng R, Tsatsos J, Briones-Urbina R, O’Dowd BF. Cloning, characterization, and distribution of a mu-opioid receptor in rat brain. J Neurochem 1994;62(6):2099–105.
   PubMed Web of Science ®Google Scholar
• Zhu ZP, Badisa RB, Palm DE, Goodman CB. Regulation of rat MOR-1 gene expression after chronic intracerebroventricular administration of morphine. Mol Med Rep 2012;5(2):513–16. doi:10.3892/mmr.2011.677.
   PubMed Web of Science ®Google Scholar
• Allouche S, Noble F, Marie N. Opioid receptor desensitization: mechanisms and its link to tolerance. Front Pharmacol 2014;5:280. doi:10.3389/fphar.2014.00280.
   PubMed Web of Science ®Google Scholar
• Bot G, Blake AD, Li S, Reisine T. Fentanyl and its analogs desensitize the cloned mu opioid receptor. J Pharmacol Exp Ther 1998;285(3):1207–18.
   PubMed Web of Science ®Google Scholar
• Nowoczyn M, Marie N, Coulbault L, Hervault M, Davis A, Hanouz JL, Allouche S. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor. Neuropharmacology 2013;73:368–79. doi:10.1016/j.neuropharm.2013.06.010.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, Self DW. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci USA 2001;98(20):11042–46. doi:10.1073/pnas.191352698.
   PubMed Web of Science ®Google Scholar
• Li J, Li YH, Yuan XR. Changes of phosphorylation of cAMP response element binding protein in rat nucleus accumbens after chronic ethanol intake: naloxone reversal. Acta Pharmacol Sin 2003;24(9):930–36.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Reflections on: “A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function”. Brain Res 2016;1645:71–74. doi:10.1016/j.brainres.2015.12.039.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Hyman SE, Malenka RC. Molecular neuropharmacology: a foundation for clinical neuroscience, 3rd. New York, NY: McGraw-Hill Education; 2015.
   Google Scholar
• Briand LA, Blendy JA. Molecular and genetic substrates linking stress and addiction. Brain Res 2010;1314:219–34. doi:10.1016/j.brainres.2009.11.002.
   PubMed Web of Science ®Google Scholar
• Carlezon WA Jr., Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005;28(8):436–45. doi:10.1016/j.tins.2005.06.005.
   PubMed Web of Science ®Google Scholar
• McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 2003;6(11):1208–15. doi:10.1038/nn1143.
   PubMed Web of Science ®Google Scholar
• Zhang M, Jing L, Liu Q, Wen RT, Li JX, Li YL, Gong Q, Liang JH. Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine. Neurosci Lett 2012;520(1):87–91. doi:10.1016/j.neulet.2012.05.037.
   PubMed Web of Science ®Google Scholar
• Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, et al. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 2006;9(2):205–11. doi:10.1038/nn1636.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Transcriptional mechanisms of drug addiction. Clin psychopharmacol neurosci 2012;10(3):136–43. doi:10.9758/cpn.2012.10.3.136.
   PubMedGoogle Scholar